Disclosing false‐positive rates in the report: Useful or not?

In this issue, Poller and Schmitt provide an overview of false‐positive rates for cytologic interpretations of malignancy in different specimen types and ask an intriguing question: Should a malignant diagnosis include an acknowledgment of the risk of a false‐positive based on published literature? [ABSTRACT FROM AUTHOR]